| Drug Name |
Clorazepate dipotassium |
| Drug ID |
BADD_D00506 |
| Description |
A water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions. |
| Indications and Usage |
For the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Also used as adjunctive therapy in the management of partial seizures and for the symptomatic relief of acute alcohol withdrawal. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
N05BA05 |
| DrugBank ID |
DB00628
|
| KEGG ID |
D00694
|
| MeSH ID |
D003009
|
| PubChem ID |
167305
|
| TTD Drug ID |
D0P3JU
|
| NDC Product Code |
0378-0040; 0378-0070; 43063-030; 55292-304; 51672-4042; 51672-4044; 13107-321; 51672-4043; 43063-893; 13107-319; 13107-320; 0378-0030; 12828-0019; 69037-0067 |
| Synonyms |
Clorazepate Dipotassium | Dipotassium Chlorazepate | 4306-CB | Chlorazepate | Clorazepate | Tranxene | Tranxilium | Clorazepic Acid | Clorazepate Monopotassium |
